Page 3 - Best Uterine cancer doctors: TOP 102 doctors

Director of Oncology Hospitalization at Tel Aviv Medical Center (Ichilov). Dr. Stepfansky brings deep expertise in managing complex uterine cancer cases.

• Board-certified in oncology with 26 years of experience of experience
• Primary researcher in multiple clinical trials on new cancer treatments
• Specialized training at Ichilov – one of Israel's leading cancer centers

Dr. Yildiz has published extensively on gynecologic oncology, including research on endometrial cancer and paraneoplastic syndromes.

• Co-authored studies on megestrol acetate effects in endometrial cancer
• Published case reports on rare gynecologic oncology presentations
• Member of research teams investigating novel oncology treatments
• Works at Medipol Mega University Hospital's oncology department

Dr. Topcu specializes in uterine cancer treatment with extensive international training at top cancer centers like MD Anderson and Moffit.

• Medical oncology specialist with 18 years of experience of experience
• Trained at MD Anderson Cancer Center and Sunnybrook Odette Cancer Center
• Expert in gynecological cancers including uterine and ovarian
• Works at Valued Med Hub Hospitals

Specialist in urogenital cancers with a focus on research-backed treatments – Dr. Sec serves as the Turkish Medical Oncology Association's Specialist Physicians Representative.

• Over 14 years of experience of experience in medical oncology
• Published multiple studies on cancer treatment outcomes
• Member of Turkish Medical Oncology Association
• Works at Bahçelievler Medikalpark Hospital

Dr. Rabin coordinates cancer care at Tel Hashomer's Sheba Hospital and trained at the top-ranked MD Anderson Cancer Center.

• Completed residency in oncology and radiotherapy
• Fellowship in gynecologic oncology at MD Anderson
• Extensive experience treating female reproductive system tumors
• Investigator in novel MRI-guided ultrasound ablation research
• Member of the American Society for Radiation Oncology

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over 2016 years of experience of experience in oncology
• Trained at Selcuk University's Faculty of Medicine
• Previously worked at Ankara Oncology Clinic
• Promoted to Associate Professor in 2016

Prof. Cemil Bilir specializes in uterine cancer with dual expertise in medical oncology and inorganic chemistry research.

• 21 years of experience in oncology with subspecialty training from Cleveland Clinic
• Professor at Sakarya University – leader in oncology education
• Member of ASCO, ESMO, and Turkish Society of Medical Oncology
• Conducts cancer research alongside clinical practice

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Nail Paksoy specializes in uterine cancer treatment at Medipol Bahçelievler Hospital, with extensive research in gynecologic oncology.

• ESMO Board Certified in Medical Oncology
• Published multiple studies on endometrial cancer treatments
• Participated in international clinical trials for advanced endometrial cancer
• Fellowship-trained at Istanbul University Oncology Institute

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Inta Jaunalksne specializes in virotherapy, a cutting-edge immunology field, with 49 years of experience of experience.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with an internship in Internal Medicine
• Focuses on innovative immunology treatments

Dr. Alemdar specializes in uterine cancer with extensive training in medical oncology from Akdeniz University.

• Over 20 years of experience experience in oncology
• Trained at Akdeniz University, a leading medical institution
• Works at Medical Park Antalya Hospital Complex

Dr. Ozden brings over 27 years of experience of medical experience, specializing in oncology with a focus on uterine cancer at VM Medical Park Pendik Hospital.

• Graduated from Istanbul University's prestigious Cerrahpaşa Faculty of Medicine
• Completed Medical Oncology subspecialty at Kocaeli University
• Extensive experience in both public and private hospital settings
• Practiced internal medicine before specializing in oncology

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Hisham Khalifa is a Consultant Surgical Oncologist. He assesses, diagnoses, and operates on gynecological cancers, including ovarian, uterine, cervical, vaginal, and vulval cancers. He performs both minimally invasive (laparoscopic) and open surgery.

Career milestones: Resident and faculty member at the National Cancer Institute, Cairo University (2001–2014). Assistant Professor at AlFaisal University and Assistant Consultant at King Faisal Hospital and Research Center (KFSHRC), Riyadh (2014–2019). Consultant at the NCI, Cairo (2019–present); Director of the Professional Diploma in Gyne-Onco Surgery. Consultant at the Oncology Pediatric Hospital–Alexandria University and Shefa Al Orman Comprehensive Cancer Center, Luxor (2020–present).

Credentials: MBBCh (1999); Master’s in General Surgery (2004); Doctorate in Surgical Oncology (2008); Fellowship of the European Board of Surgery (FEBS, UEMS). Memberships: FACS; SSO; ESSO; ECS; EGSSO.